Ocular findings in systemic lupus erythematosus

Samir S Shoughy, Khalid F Tabbara, Samir S Shoughy, Khalid F Tabbara

Abstract

Systemic lupus erythematosus (SLE) is a chronic multisystem autoimmune disease. Ocular complications occur in up to one-third of patients with SLE. The ocular findings may represent the initial manifestation of the disease and may lead to severe ocular morbidity and loss of vision. Early diagnosis and prompt management of patients with SLE are mandatory and require collaboration between the ophthalmologist and the rheumatologist.

Keywords: Autoimmune; Ocular complications; SLE.

References

    1. Sivaraj R.R., Durrani O.M., Denniston A.K., Murray P.I., Gordon C. Ocular manifestations of systemic lupus erythematosus. Rheumatology. 2007;46:1757–1762.
    1. Read R.W. Clinical min-review systemic erythematosus and the eye. Ocul Immunol Inflamm. 2004;12:87–99.
    1. Davies J.B., Rao P.K. Ocular manifestations of systemic lupus erythematosus. Curr Opin Ophthalmol. 2008;19:512.
    1. Tan E.M., Cohen A.S., Fries J.F. The 1982 revised criteria for classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25:1271–1277.
    1. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725.
    1. Palejwala N.V., Walia H.S., Yeh S. Ocular manifestations of systemic lupus erythematosus: a review of the literature. Autoimmune Dis. 2012;2012:290898.
    1. Siebert S., Srinivasan U. Proptosis can be the presenting feature of systemic lupus erythematosus. Ann Rheum Dis. 2004;63(8):908–909.
    1. Serop S., Vianna R.N., Claeys M., De Laey J.J. Orbital myositis secondary to systemic lupus erythematosus. Acta Ophthalmol (Copenh) 1994;72(4):520–523.
    1. Stavrou P., Murray P.I., Batta K., Gordon C. Acute ocular ischaemia and orbital inflammation associated with systemic lupus erythematosus. Brit J Ophthalmol. 2002;86(4):474–475.
    1. Arrico L., Abbouda A., Bianchi S., Malagola R. Acute monolateral proptosis and orbital myositis in a patient with discoid lupus erythematosus: a case report. J Med Case Rep. 2014;8:375.
    1. Vattoth S., Curé J.K. CT imaging of head and neck lupus panniculitis. AJNR Am J Neuroradiol. 2009 Jun;30(6):1131–1133.
    1. Arrico L., Abbouda A., Abicca I., Malagola R. Ocular complications in cutaneous lupus erythematosus: a systematic review with a meta-analysis of reported cases. J Ophthalmol. 2015;2015:254260.
    1. Tabbara K.F., 1, Vera-Cristo C.L. Sjögren syndrome. Curr Opin Ophthalmol. 2000;11(6):449–454.
    1. Baker M.G., Cresce N.D., Ameri M., Martin A.A., Patterson J.W., Kimpel D.L. Systemic lupus erythematosus presenting as Stevens–Johnson syndrome/toxic epidermal necrolysis. J Clin Rheumatol. 2014;20(3):167–171.
    1. Jensen J.L., Bergem H.O., Gilboe I.M. Oral and ocular sicca symptoms and findings are prevalent in systemic lupus erythematosus. J Oral Pathol Med. 1999;28(7):317–322.
    1. Moscovici B.K., Holzchuh R., Chiacchio B.B., Santo R.M., Shimazaki J., Hida R.Y. Clinical treatment of dry eye using 0.03% tacrolimus eye drops. Cornea. 2012;31(8):945–949.
    1. Messmer E.M., Foster C.S. Vasculitic peripheral ulcerative keratitis. Surv Ophthalmol. 1999;43(5):379–396.
    1. Halmay O., Ludwig K. Bilateral band-shaped deep keratitis and iridocyclitis in systemic lupus erythematosus. Brit J Ophthalmol. 1964;48:558–562.
    1. Ruusuvaara P., Setala K. Keratoendotheliitis fugax hereditaria. A clinical and specular microscopic study of a family with dominant inflammatory corneal disease. Acta Ophthalmol. 1987;65(2):159–169.
    1. Nemet A.Y., Vinker S., Bahar I., Kaiserman I. The association of keratoconus with immune disorders. Cornea. 2010;29(11):1261–1264.
    1. Watson P.G., Hayreh S.S. Scleritis and episcleritis. Brit J Ophthalmol. 1976;60:163.
    1. Sainz de la Maza M., Jabbur N.S., Foster C.S. Severity of scleritis and episcleritis. Ophthalmology. 1994;101:389.
    1. Wong R.W., Chan A., Johnson R.N., McDonald H.R., Kumar A., Gariano R. Posterior scleritis in patients with systemic lupus erythematosus. Retin Cases Brief Rep. 2010;4(4):326–331.
    1. Harvey A.M., Shulman L.E., Tumulty P.A. Systemic lupus erythematosus: review of the literature and clinical analysis of 138 cases. Medicine. 1954;33:291.
    1. Gallagher K., Viswanathan A., Okhravi N. Association of systemic lupus erythematosus with uveitis. JAMA Ophthalmol. 2015 Oct 1;133(10):1190–1193.
    1. Zink J.M., Singh-Parikshak R., Johnson C.S., Zacks D.N. Hypopyon uveitis associated with systemic lupus erythematosus and antiphospholipid antibody syndrome. Graefes Arch Clin Exp Ophthalmol. 2005;243(4):386–388.
    1. Silpa-archa S., Lee J.J., Foster C.S. Ocular manifestations in systemic lupus erythematosus. Brit J Ophthalmol. 2016;100:135–141.
    1. Ushiyama O., Ushiyama K., Koarada S. Retinal disease in patients with systemic lupus erythematosus. Annals Rheum Diseases. 2000;59(9):705–708.
    1. Coppeto J., Lessel S. Retinopathy in systemic lupus erythematosus. Arch Ophalmol. 1977;95:794–797.
    1. Jabs D.A., Fine S.L., Hochberg M.C. Severe retinal vaso-occlusive disease in systemic lupus erythematosus. Arch Ophalmol. 1986;104:558–563.
    1. Hall S., Buettner H., Luthra H.S. Occlusive retinal vascular disease in systemic lupus erythematosus. J Rheumatol. 1984;11:846–850.
    1. Lanham J.G., Barrie T., Kohner E.M., Hughes G.R.V. SLE retinopathy: evaluation by fluorescein angiography. Ann Rheum Dis. 1982;41:473–478.
    1. Shein J., Shukla D., Reddy S., Yannuzzi L.A., Cunningham E.T., Jr. Macular infarction as a presenting sign of systemic lupus erythematosus. Retin Cases Brief Rep. 2008;2(1):55–60. Winter.
    1. Cunningham E.T., Jr, Alfred P.R., Irvine A.R. Central serous chorioretinopathy in patients with systemic lupus erythematosus. Ophthalmology. 1996;103:2081–2090.
    1. N guyen Q.D., Uy H.S., Akpek E.K. Choroidopathy of systemic lupus erythematosus. Lupus. 2000;9(4):288–298.
    1. Arevalo J.F., Lowder C.Y., Muci-Mendoza R. Ocular manifestations of systemic lupus erythematosus. Curr Opin Ophthalmol. 2002;13:404–410.
    1. Feinglass E.J., Arnett F.C., Dorsch C.A. Neuropyschiatric manifestations of systemic lupus erythematosus: diagnosis, clinical spectrum, and relations to other features of the disease. Medicine. 1976;55(4):323–329.
    1. Keane J. Eye movement abnormalities in systemic lupus erythematosus. Arch Neurol. 1995;52:1145–1149.
    1. Klippel J.H., Zwaifl er N.J. Neuropsychiatric abnormalities in systemic lupus erythematosus. Clin Rheum Dis. 1975;1:621.
    1. Lacava A.C. Ocular complications of chloroquine and derivatives therapy. Arq Bras Oftalmol. 2010;73(4):384–389.
    1. Geamănu Pancă A., Popa-Cherecheanu A., Marinescu B. Retinal toxicity associated with chronic exposure to hydroxychloroquine and its ocular screening. Rev J Med Life. 2014;7(3):322–326. 15.
    1. Marmor M.F., Kellner U., Lai T.Y. Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy. Ophthalmology. 2011;118(2):415–422.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi